You are currently on the new version of our website. Access the old version .

22 Results Found

  • Article
  • Open Access
1,249 Views
12 Pages

Pregnane X receptor (PXR) is an important nuclear receptor that regulates diverse physiological functions, including drug metabolism. Although PXR activation is potentially involved in adverse events, the full scope of its impact has yet to be elucid...

  • Article
  • Open Access
41 Citations
7,908 Views
14 Pages

Oxygenated Polyketides from Plakinastrella mamillaris as a New Chemotype of PXR Agonists

  • Carmen Festa,
  • Claudio D'Amore,
  • Barbara Renga,
  • Gianluigi Lauro,
  • Simona De Marino,
  • Maria Valeria D'Auria,
  • Giuseppe Bifulco,
  • Angela Zampella and
  • Stefano Fiorucci

2 July 2013

Further purification of the apolar extracts of the sponge Plakinastrella mamillaris, afforded a new oxygenated polyketide named gracilioether K, together with the previously isolated gracilioethers E–G and gracilioethers I and J. The structure of the...

  • Review
  • Open Access
9 Citations
4,209 Views
18 Pages

Current Therapies for Cholestatic Diseases

  • Nahum Méndez-Sánchez,
  • Carlos E. Coronel-Castillo and
  • Ana L. Ordoñez-Vázquez

Cholestasis is a condition characterized by decrease in bile flow due to progressive pathological states that lead to chronic cholestatic liver diseases which affect the biliary tree at the intrahepatic level and extrahepatic level. They induce compl...

  • Article
  • Open Access
19 Citations
4,062 Views
11 Pages

The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor

  • Nicolas Creusot,
  • Matthieu Gassiot,
  • Elina Alaterre,
  • Barbara Chiavarina,
  • Marina Grimaldi,
  • Abdelhay Boulahtouf,
  • Lucia Toporova,
  • Sabine Gerbal-Chaloin,
  • Martine Daujat-Chavanieu and
  • Patrick Balaguer
  • + 5 authors

8 July 2020

The human pregnane X receptor (hPXR) is activated by a large set of endogenous and exogenous compounds and plays a critical role in the control of detoxifying enzymes and transporters regulating liver and gastrointestinal drug metabolism and clearanc...

  • Article
  • Open Access
14 Citations
6,905 Views
8 Pages

Chalinulasterol, a Chlorinated Steroid Disulfate from the Caribbean Sponge Chalinula molitba. Evaluation of Its Role as PXR Receptor Modulator

  • Roberta Teta,
  • Gerardo Della Sala,
  • Barbara Renga,
  • Alfonso Mangoni,
  • Stefano Fiorucci and
  • Valeria Costantino

14 June 2012

Chalinulasterol (1) a new chlorinated sterol disulfate was isolated from the Caribbean sponge Chalinula molitba. Its structure was elucidated using mass spectrometry and NMR experiments. The possible role of chalinulasterol as modulator of the PXR nu...

  • Article
  • Open Access
30 Citations
8,428 Views
18 Pages

Solomonsterol A, a Marine Pregnane-X-Receptor Agonist, Attenuates Inflammation and Immune Dysfunction in a Mouse Model of Arthritis

  • Andrea Mencarelli,
  • Claudio D'Amore,
  • Barbara Renga,
  • Sabrina Cipriani,
  • Adriana Carino,
  • Valentina Sepe,
  • Elisa Perissutti,
  • Maria Valeria D'Auria,
  • Angela Zampella and
  • Stefano Fiorucci
  • + 1 author

24 December 2013

In the present study we provide evidence that solomonsterol A, a selective pregnane X receptor (PXR) agonist isolated from the marine sponge Theonella swinhoei, exerts anti-inflammatory activity and attenuates systemic inflammation and immune dysfunc...

  • Communication
  • Open Access
3 Citations
1,940 Views
12 Pages

Pregnenolone 16-Alpha Carbonitrile, an Agonist of Rodent Pregnane X Receptor, Regulates Testosterone Biosynthesis in Rodent Leydig Cells

  • Julia M. Salamat,
  • Elizabeth M. Ayala,
  • Chen-Che J. Huang,
  • Frank S. Wilbanks,
  • Rachel C. Knight,
  • Benson T. Akingbemi and
  • Satyanarayana R. Pondugula

16 September 2024

Leydig cells (LCs) in the testes produce the male sex hormone testosterone (T). Several xenobiotics, including clinical drugs, supplements, and environmental chemicals, are known to disrupt T homeostasis. Notably, some of these xenobiotics are known...

  • Article
  • Open Access
17 Citations
4,099 Views
21 Pages

PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1

  • Alice Matheux,
  • Matthieu Gassiot,
  • Gaëlle Fromont,
  • Fanny Leenhardt,
  • Abdelhay Boulahtouf,
  • Eric Fabbrizio,
  • Candice Marchive,
  • Aurélie Garcin,
  • Hanane Agherbi and
  • Philippe Pourquier
  • + 6 authors

20 July 2021

Resistance to castration is a crucial issue in the treatment of metastatic prostate cancer. Kinase inhibitors (KIs) have been tested as potential alternatives, but none of them are approved yet. KIs are subject of extensive metabolism at both the hep...

  • Review
  • Open Access
8 Citations
4,774 Views
15 Pages

Pregnane X Receptor Signaling Pathway and Vitamin K: Molecular Mechanisms and Clinical Relevance in Human Health

  • Jeff L. Staudinger,
  • Avina Mahroke,
  • Gauri Patel,
  • Cole Dattel and
  • Sahana Reddy

14 April 2024

This review explores the likely clinical impact of Pregnane X Receptor (PXR) activation by vitamin K on human health. PXR, initially recognized as a master regulator of xenobiotic metabolism in liver, emerges as a key regulator influencing intestinal...

  • Feature Paper
  • Article
  • Open Access
734 Views
18 Pages

25 July 2025

The nuclear receptors pregnane X receptor (PXR), constitutive androstane receptor (CAR), and farnesoid X receptor (FXR) regulate the hepatic metabolism of androstenone, a testicular steroid that accumulates in the fat of intact male pigs and causes b...

  • Article
  • Open Access
7 Citations
5,464 Views
20 Pages

Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC Library

  • Enni-Kaisa Mustonen,
  • Tatu Pantsar,
  • Azam Rashidian,
  • Juliander Reiner,
  • Matthias Schwab,
  • Stefan Laufer and
  • Oliver Burk

12 April 2022

Small-molecule protein kinase inhibitors are used for the treatment of cancer, but off-target effects hinder their clinical use. Especially off-target activation of the pregnane X receptor (PXR) has to be considered, as it not only governs drug metab...

  • Review
  • Open Access
3 Citations
3,037 Views
31 Pages

Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer

  • Yuanbo Bi,
  • Sifan Liu,
  • Lei Wang,
  • Daiyin Peng,
  • Weidong Chen,
  • Yue Zhang and
  • Yanyan Wang

20 August 2025

The pregnane X receptor (PXR), a ligand-activated nuclear receptor, plays a central role in regulating the metabolism of both endogenous substances and xenobiotics. In recent years, increasing evidence has highlighted its involvement in chronic disea...

  • Article
  • Open Access
20 Citations
4,027 Views
20 Pages

Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer

  • Xiaxia Niu,
  • Ting Wu,
  • Qishuang Yin,
  • Xinsheng Gu,
  • Gege Li,
  • Changlong Zhou,
  • Mei Ma,
  • Li Su,
  • Shu Tang and
  • Hongmei Cui
  • + 2 authors

1 October 2022

Paclitaxel (PTX) is one of the most efficient drugs for late-stage non-small cell lung cancer (NSCLC) patients. However, most patients gradually develop resistance to PTX with long-term treatments. The identification of new strategies to reverse PTX...

  • Feature Paper
  • Article
  • Open Access
53 Citations
5,399 Views
14 Pages

PXR Functionally Interacts with NF-κB and AP-1 to Downregulate the Inflammation-Induced Expression of Chemokine CXCL2 in Mice

  • Maya Okamura,
  • Ryota Shizu,
  • Taiki Abe,
  • Susumu Kodama,
  • Takuomi Hosaka,
  • Takamitsu Sasaki and
  • Kouichi Yoshinari

15 October 2020

Pregnane X receptor (PXR) is a liver-enriched xenobiotic-responsive transcription factor. Although recent studies suggest that PXR shows anti-inflammatory effects by suppressing nuclear factor kappa B (NF-κB), the detailed mechanism remains unc...

  • Article
  • Open Access
5 Citations
1,841 Views
37 Pages

Impact of Persistent Endocrine-Disrupting Chemicals on Human Nuclear Receptors: Insights from In Silico and Experimental Characterization

  • Harrish Ganesh,
  • James Moran,
  • Saptarshi Roy,
  • Joshua Mathew,
  • Jehosheba Ackah-Blay,
  • Ellen Costello,
  • Priya Shan and
  • Sivanesan Dakshanamurthy

Endocrine-disrupting chemicals (EDCs) are notable for their persistence, bioaccumulation, and associations with cancer. Human nuclear receptors (hNRs) are primary targets disrupted by these persistent EDCs, resulting in alterations to xenobiotic meta...

  • Review
  • Open Access
16 Citations
9,606 Views
21 Pages

Allopregnanolone: Metabolism, Mechanisms of Action, and Its Role in Cancer

  • Carmen J. Zamora-Sánchez and
  • Ignacio Camacho-Arroyo

29 December 2022

Allopregnanolone (3α-THP) has been one of the most studied progesterone metabolites for decades. 3α-THP and its synthetic analogs have been evaluated as therapeutic agents for pathologies such as anxiety and depression. Enzymes involved i...

  • Article
  • Open Access
22 Citations
4,455 Views
18 Pages

6 December 2018

Ten new triterpenoid compounds with structure diversity of the C-17 side-chain, including nine tirucallanes, named xylocarpols A–E (1–5) and agallochols A–D (6–9), and an apotirucallane, named 25-dehydroxy protoxylogranatin B...

  • Article
  • Open Access
12 Citations
3,423 Views
22 Pages

(-)-Epicatechin Is a Biased Ligand of Apelin Receptor

  • Andrés Portilla-Martínez,
  • Miguel Ángel Ortiz-Flores,
  • Eduardo Meaney,
  • Francisco Villarreal,
  • Nayelli Nájera and
  • Guillermo Ceballos

11 August 2022

(-)-Epicatechin (EC) is part of a large family of biomolecules called flavonoids and is widely distributed in the plant kingdom. Several studies have shown the beneficial effects of EC consumption. Many of these reported effects are exerted by activa...

  • Article
  • Open Access
7 Citations
3,503 Views
15 Pages

Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists

  • Claudia Finamore,
  • Carmen Festa,
  • Bianca Fiorillo,
  • Francesco Saverio Di Leva,
  • Rosalinda Roselli,
  • Silvia Marchianò,
  • Michele Biagioli,
  • Lucio Spinelli,
  • Stefano Fiorucci and
  • Simona De Marino
  • + 2 authors

21 March 2023

Compounds featuring a 1,2,4-oxadiazole core have been recently identified as a new chemotype of farnesoid X receptor (FXR) antagonists. With the aim to expand this class of compounds and to understand the building blocks necessary to maintain the ant...

  • Article
  • Open Access
8 Citations
6,122 Views
16 Pages

Metabolism of the Marine Phycotoxin PTX-2 and Its Effects on Hepatic Xenobiotic Metabolism: Activation of Nuclear Receptors and Modulation of the Phase I Cytochrome P450

  • Jimmy Alarcan,
  • Estelle Dubreil,
  • Antoine Huguet,
  • Dominique Hurtaud-Pessel,
  • Stefanie Hessel-Pras,
  • Alfonso Lampen,
  • Valérie Fessard and
  • Ludovic Le Hegarat

5 July 2017

PTX-2 is a marine biotoxin frequently found in shellfish that can lead to food intoxication in humans. Information regarding PTX-2 metabolism is scarce, and little is known of its effect on xenobiotic-metabolizing enzymes (XME) or its molecular pathw...

  • Article
  • Open Access
2 Citations
1,916 Views
26 Pages

30 August 2024

Presently, a major challenge is the search for new compounds that may exhibit an inhibitory effect on tumor progression. Recently, the 4-thiazolidinone (4-TZD) group has gained attention in this research field. The aim of the present study was to eva...

  • Article
  • Open Access
13 Citations
4,533 Views
16 Pages

High Content Screening Using New U2OS Reporter Cell Models Identifies Harmol Hydrochloride as a Selective and Competitive Antagonist of the Androgen Receptor

  • Hadjer Dellal,
  • Abdelhay Boulahtouf,
  • Elina Alaterre,
  • Alice Cuenant,
  • Marina Grimaldi,
  • William Bourguet,
  • Céline Gongora,
  • Patrick Balaguer and
  • Philippe Pourquier

16 June 2020

Prostate cancer is the most commonly diagnosed malignancy in men. Its growth mainly relies on the activity of the androgen receptor (AR), justifying the use of androgen deprivation therapy as a gold standard treatment for the metastatic disease. Inhi...